At #ESMO26 Peter Forsyth, MD (@PeterForsyth27) shares promising results from new research on leptomeningeal disease in women with breast cancer. Phase 1 results show intrathecal dendritic cell therapy was well tolerated, with encouraging immune activity, paving the way for further study. #MoffittESMO26
Had a fantastic visit to the world-renowned Duke Brain Tumor Center during its annual Research Day. I’m extremely grateful for the opportunity to attend, listen to the outstanding brain tumor research being conducted, and meet such an incredibly talented and smart group of people.
I had the chance to reconnect with many old friends and learn about exciting advances in science, including an updated presentation by Matthias Gromeier on the modified poliovirus, which provided extraordinary detail on the mechanism of immune activation. I am also very grateful to José Conejo-Garcia for his invitation. He is an outstanding immunologist whose scientific work initiative the Kartik clinical trial in ovarian cancer at Moffitt Cancer Center. #MoffittNews#MoffittResearch
Had a super great meeting at ESMO in Madrid! I gave a talk about our intrathecal DC therapy phase 1 for LMD. It was a great session with great chairs and great questions were very helpful. All the presentations were fantastic and very interesting, and the discussions were very useful. I love ESMO! #ESMO2026#MoffittNews
Congratulations to the great Dr. Pina on her state-of-the-art review on LMD arising from last year's LMD THINK TANK at the SNO ASCO Brain Mets Meeting! Great paper and it made it to the cover of Neuro-Oncology which is the best journal in the field. Great work Dr. Pina and Thanks for being part of the Moffitt TEAM! #MoffittNews
THE JKTG Foundation had an amazing meeting a couple of weeks ago in Washington, DC with Mr. Ted Giovanis. Who founded his own cancer research foundation when his wife succumbed to breast cancer. He is an amazing man and inspiration when he turned this awful personal experience into a Foundation to find cancer cures. Great talks, great people and a great setting and I learned a lot!
It was an amazingly great meeting. #MoffittNews#JKTG
A Man In Action Ted Giovanis and his foundation:
The Great meeting in Washington at the annual presentations of the JKTG Foundation symposium I'm extremely grateful to have been invited and made all these wonderful leaders in the field. Ted is amazing, in all the ways one could react to the illness in your spouse. You chose to get involved with the Research funding effort which is extremely important now. As a fantastic and creative symposium with great speakers and we had a bunch new collaborations to make to see if we can Cure Breast Cancer leptomeningeal disease! #MoffittNews#JKTG
I’m headed to #SITC26! I am looking forward to sharing my research, (#506) Preclinical Evaluation of Intrathecal TRP1-Targeted CAR-T Cells Demonstrates Durable Antitumor Immunity in Melanoma Leptomeningeal Disease, with attendees at the meeting in Phoenix! @sitcancer@MoffittResearch@MoffittNews
Learn more and register: sitcancer.org/2026/home@sitc…
🎉 I am proud to share that I have been selected to receive the 2026 CNS Metastases Award for my abstract, “A First in Human Phase 1 Study of Intrathecal Peptide-Pulsed Dendritic Cells for HER2+ and Triple Negative Breast Cancer Leptomeningeal Disease.” This recognition reflects the dedication of our entire research team and our commitment to advancing innovative treatment options for patients with leptomeningeal disease. I am honored that this work will be featured at the upcoming 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia. Thank you to my colleagues, collaborators, and patients who make this work possible. Looking forward to continuing our efforts to improve outcomes for patients facing these challenging diagnoses.
@MoffittNews#NeuroOncology#CancerResearch#BreastCancerResearch#SNO2026#InnovationInMedicine#BrainTumorResearch 📷
🎉 I am proud to share that I have been selected to receive the 2026 CNS Metastases Award for my abstract, “A First in Human Phase 1 Study of Intrathecal Peptide-Pulsed Dendritic Cells for HER2+ and Triple Negative Breast Cancer Leptomeningeal Disease.”
This recognition reflects the dedication of our entire research team and our commitment to advancing innovative treatment options for patients with leptomeningeal disease. I am honored that this work will be featured at the upcoming 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia.
Thank you to my colleagues, collaborators, and patients who make this work possible. Looking forward to continuing our efforts to improve outcomes for patients facing these challenging diagnoses. @MoffittNews#NeuroOncology#CancerResearch#BreastCancerResearch#SNO2026#InnovationInMedicine#BrainTumorResearch 🧠🔬🏆
Honored to serve as the keynote speaker at the 23rd Annual Retreat hosted by the Brain Tumor Center of Excellence at Atrium Health Wake Forest Baptist Comprehensive Cancer Center. I enjoyed discussing innovative approaches to treating leptomeningeal disease and collaborating with colleagues dedicated to advancing neuro-oncology research and patient care. @MoffitNews @MoffittResearch#BrainTumorResearch#CancerResearch
Great dinner at the oldest restaurant in Boston for SNO/ASCO 2026. I learned alot. It always great to touch base with friends and colleagues. #MoffittNews
Great talks at #ASCO26 in Neuro oncology! Here’s a brief interview highlighting our work. Watch the videos here: Peter Forsyth interviews @NewsMoffitt@VJOncology
Here is the link to the videos from my interview: vjoncology.com/?s=Peter+Fors….